| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
143,403 | 55,283 | 891 | ||||
In process research and development | ||||||
3,600 | 49,659 | 5,500 | ||||
General and administrative | ||||||
39,136 | 44,051 | 262 | ||||
Total operating expenses | ||||||
186,139 | 148,993 | 6,653 | ||||
Loss from operations | ||||||
-186,139 | -148,993 | -6,653 | ||||
Other income, net | ||||||
5,832 | 2,024 | -118 | ||||
Net loss | ||||||
-180,307 | -146,969 | -6,771 | ||||
Other comprehensive income: | ||||||
Foreign currency translation, net of tax | ||||||
-12 | - | - | ||||
Other comprehensive income (loss) | ||||||
319 | -61 | - | ||||
Unrealized gain (loss) on marketable securities, net of tax | ||||||
331 | -61 | - | ||||
Comprehensive loss | ||||||
-179,988 | -147,030 | -6,771 | ||||
Net loss per share, basic and diluted | ||||||
-3.29 | -22.59 | -0.74 | ||||
Weighted average common shares outstanding, basic and diluted | ||||||
54,740 | 6,504 | 9,160 | ||||